Arvinas Inc. Common Stock
ARVNUnited States
5 filed reports · 216 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 900 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 678 | Dec 2025 |
Financial data
216 concepts · 1,578 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial203 concepts · 1,371 facts · Dec 2023 to Jun 2026
- Ending balance19 · Dec 2023 to Jun 2026
- Accounts receivable net current13 · Dec 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents13 · Dec 2023 to Jun 2026
- Contract with customer asset net13 · Dec 2023 to Jun 2026
- Contract with customer liability13 · Dec 2023 to Jun 2026
- Stockholders equity (US GAAP)13 · Dec 2023 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value12 · Dec 2023 to Jun 2026
- Allocated share based compensation expense12 · Dec 2023 to Jun 2026
- Comprehensive income net of tax12 · Dec 2023 to Jun 2026
- Depreciation and amortization12 · Dec 2023 to Jun 2026
- General and administrative expense (US GAAP)12 · Dec 2023 to Jun 2026
- Income tax expense benefit12 · Dec 2023 to Jun 2026
- Investment income interest12 · Dec 2023 to Jun 2026
- Net income loss12 · Dec 2023 to Jun 2026
- Nonoperating income expense12 · Dec 2023 to Jun 2026
- Operating expenses (US GAAP)12 · Dec 2023 to Jun 2026
- Operating income loss12 · Dec 2023 to Jun 2026
- Operating lease cost12 · Dec 2023 to Jun 2026
- Other comprehensive income availableforsale securities adjustment net of tax portion attributable to parent12 · Dec 2023 to Jun 2026
- Other nonoperating income expense12 · Dec 2023 to Jun 2026
- Research and development expense12 · Dec 2023 to Jun 2026
- Revenue12 · Dec 2023 to Jun 2026
- Accretion amortization of discounts and premiums investments11 · Dec 2023 to Jun 2026
- Capitalized contract cost amortization11 · Dec 2023 to Jun 2026
Segment13 concepts · 207 facts · Dec 2023 to Jun 2026
- Program-specific external expense83 · Dec 2023 to Jun 2026
- General and administrative expense (US GAAP)12 · Dec 2023 to Jun 2026
- Income tax expense benefit12 · Dec 2023 to Jun 2026
- Investment income interest12 · Dec 2023 to Jun 2026
- Labor and related expense12 · Dec 2023 to Jun 2026
- Net income loss12 · Dec 2023 to Jun 2026
- Non program-specific external expense12 · Dec 2023 to Jun 2026
- Other research and development expense12 · Dec 2023 to Jun 2026
- Research and development expense12 · Dec 2023 to Jun 2026
- Segment reporting other item amount12 · Dec 2023 to Jun 2026
- Revenue11 · Dec 2023 to Mar 2026
- Income loss from equity method investments3 · Dec 2023 to Dec 2025
- Cost of license revenue2 · Jun 2025 to Jun 2026
Segments
207 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 207 facts
- Reportable207 · Dec 2023 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Nov 2025 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 4, 2026
- FY2026 Q1May 12, 2026
- FY2025 Q4Feb 24, 2026
- FY2025 Q3Nov 5, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.